ProStrakan's 1st-half 2007 sales jump 15%

In its pre-close statement, Scottish drugmaker ProStrakan says that its first-half 2007 sales increased 15% over the first six months of 2006.

Revenues during the period were boosted by a strong performance from its pan-European products: Tostran (testosterone gel), Rectogesic (glyceryl trinitrate ointment, sold as Cellgesic in the USA) and droperidol, which is indicated as a premedication for anesthesia, nausea after anesthesia or for the sedation of agitated patients. Income from these three drugs grew 43%.

ProStrakan also said that it continued to see good growth in its UK market-leading product, the branded calcium and vitamin supplement Adcal D3, used as an adjunct therapy for osteoporsis, sales of which increased 12%.